MA29015B1 - Agents de liaison specifiques de l'angiopoietine-2 - Google Patents
Agents de liaison specifiques de l'angiopoietine-2Info
- Publication number
- MA29015B1 MA29015B1 MA29892A MA29892A MA29015B1 MA 29015 B1 MA29015 B1 MA 29015B1 MA 29892 A MA29892 A MA 29892A MA 29892 A MA29892 A MA 29892A MA 29015 B1 MA29015 B1 MA 29015B1
- Authority
- MA
- Morocco
- Prior art keywords
- angiopoietin
- specific binding
- binding agents
- agents
- specific
- Prior art date
Links
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US62016104P | 2004-10-19 | 2004-10-19 | |
US10/982,440 US7658924B2 (en) | 2001-10-11 | 2004-11-04 | Angiopoietin-2 specific binding agents |
Publications (1)
Publication Number | Publication Date |
---|---|
MA29015B1 true MA29015B1 (fr) | 2007-11-01 |
Family
ID=39608222
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MA29892A MA29015B1 (fr) | 2004-10-19 | 2007-05-11 | Agents de liaison specifiques de l'angiopoietine-2 |
Country Status (10)
Country | Link |
---|---|
JP (2) | JP2008520188A (hr) |
CN (1) | CN101495513B (hr) |
BR (1) | BRPI0518209A (hr) |
EA (1) | EA011866B1 (hr) |
IL (1) | IL182279A0 (hr) |
MA (1) | MA29015B1 (hr) |
MX (1) | MX2007004247A (hr) |
RU (2) | RU2404992C2 (hr) |
SG (1) | SG156668A1 (hr) |
ZA (1) | ZA200704020B (hr) |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BRPI0518209A (pt) * | 2004-10-19 | 2008-11-04 | Amgen Inc | agentes de ligação especìficos à angiopoietina-2 |
JO3182B1 (ar) * | 2009-07-29 | 2018-03-08 | Regeneron Pharma | مضادات حيوية بشرية عالية الالفة مع تولد الاوعية البشرية - 2 |
EA022546B1 (ru) * | 2011-09-28 | 2016-01-29 | Федеральное Государственное Бюджетное Учреждение Науки Институт Биоорганической Химии Им. Академиков М.М. Шемякина И Ю.А. Овчинникова Российской Академии Наук | Способ торможения роста карциномы эрлиха у лабораторного животного |
EP2760471B9 (en) * | 2011-09-30 | 2017-07-19 | Dana-Farber Cancer Institute, Inc. | Therapeutic peptides |
WO2013112438A1 (en) * | 2012-01-23 | 2013-08-01 | Regeneron Pharmaceuticals, Inc. | Stabilized formulations containing anti-ang2 antibodies |
WO2014100834A1 (en) * | 2012-12-21 | 2014-06-26 | The Regents Of The University Of California | Methods and compositions for treatment of cyanide and hydrogen sulfide toxicity |
JP6411379B2 (ja) | 2013-05-14 | 2018-10-24 | エーザイ・アール・アンド・ディー・マネジメント株式会社 | レンバチニブ化合物に対する子宮内膜がん対象の応答性を予測及び評価するためのバイオマーカー |
AR100270A1 (es) * | 2014-05-19 | 2016-09-21 | Lilly Co Eli | Anticuerpos ang2 |
ES2926687T3 (es) | 2014-08-28 | 2022-10-27 | Eisai R&D Man Co Ltd | Derivado de quinolina muy puro y método para su producción |
US20180028662A1 (en) | 2015-02-25 | 2018-02-01 | Eisai R&D Management Co., Ltd. | Method for Suppressing Bitterness of Quinoline Derivative |
CA2978226A1 (en) | 2015-03-04 | 2016-09-09 | Merck Sharpe & Dohme Corp. | Combination of a pd-1 antagonist and a vegfr/fgfr/ret tyrosine kinase inhibitor for treating cancer |
CA2988707C (en) | 2015-06-16 | 2023-10-10 | Eisai R&D Management Co., Ltd. | Combination of cbp/catenin inhibitor and immune checkpoint inhibitor for treating cancer |
CN106512006A (zh) * | 2016-07-25 | 2017-03-22 | 广州道瑞医药科技有限公司 | Angpt2分泌抑制剂在制备用于治疗血管瘤的药物中的应用 |
CN106075448A (zh) * | 2016-07-25 | 2016-11-09 | 广州道瑞医药科技有限公司 | Angpt2抑制剂在制备用于治疗血管瘤的药物中的应用 |
CN109096368B (zh) * | 2018-09-30 | 2021-07-20 | 华南理工大学 | 一种同时具有抗氧化和护肝活性的多肽及编码该多肽的基因与其制备方法和应用 |
AU2020227580A1 (en) * | 2019-02-25 | 2021-09-30 | Pharmabcine Inc. | Anti-Ang2 antibody and use thereof |
CN112126671B (zh) * | 2020-08-18 | 2021-08-31 | 中山大学附属第五医院 | 无乳链球菌Streptococus agalactiae治疗子宫内膜异位症的应用 |
CN116265487A (zh) * | 2021-12-16 | 2023-06-20 | 三优生物医药(上海)有限公司 | 抗ang2-vegf双特异性抗体及其用途 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2368670C (en) * | 1999-03-26 | 2012-06-05 | Chitra Suri | Modulation of vascular permeability by means of tie2 receptor activators |
US7205275B2 (en) * | 2001-10-11 | 2007-04-17 | Amgen Inc. | Methods of treatment using specific binding agents of human angiopoietin-2 |
US7521053B2 (en) * | 2001-10-11 | 2009-04-21 | Amgen Inc. | Angiopoietin-2 specific binding agents |
EP1458367B2 (en) * | 2001-10-12 | 2021-01-27 | Aquestive Therapeutics, Inc. | Uniform films for rapidly dissolving dosage form incorporating taste-masking compositions |
BRPI0518209A (pt) * | 2004-10-19 | 2008-11-04 | Amgen Inc | agentes de ligação especìficos à angiopoietina-2 |
-
2005
- 2005-10-19 BR BRPI0518209-3A patent/BRPI0518209A/pt not_active IP Right Cessation
- 2005-10-19 MX MX2007004247A patent/MX2007004247A/es active IP Right Grant
- 2005-10-19 EA EA200700876A patent/EA011866B1/ru not_active IP Right Cessation
- 2005-10-19 JP JP2007538066A patent/JP2008520188A/ja active Pending
- 2005-10-19 SG SG200907008-7A patent/SG156668A1/en unknown
- 2005-10-19 CN CN200580043569.5A patent/CN101495513B/zh not_active Expired - Fee Related
- 2005-10-19 RU RU2007118670/13A patent/RU2404992C2/ru not_active IP Right Cessation
-
2007
- 2007-03-28 IL IL182279A patent/IL182279A0/en unknown
- 2007-05-11 MA MA29892A patent/MA29015B1/fr unknown
- 2007-05-18 ZA ZA200704020A patent/ZA200704020B/en unknown
-
2010
- 2010-08-05 RU RU2010132956/10A patent/RU2010132956A/ru not_active Application Discontinuation
-
2011
- 2011-03-30 JP JP2011075243A patent/JP2011207882A/ja not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
EA011866B1 (ru) | 2009-06-30 |
MX2007004247A (es) | 2007-06-12 |
EA200700876A1 (ru) | 2007-10-26 |
JP2008520188A (ja) | 2008-06-19 |
RU2010132956A (ru) | 2012-02-10 |
JP2011207882A (ja) | 2011-10-20 |
SG156668A1 (en) | 2009-11-26 |
ZA200704020B (en) | 2008-06-25 |
RU2404992C2 (ru) | 2010-11-27 |
BRPI0518209A (pt) | 2008-11-04 |
RU2007118670A (ru) | 2008-12-27 |
IL182279A0 (en) | 2007-07-24 |
CN101495513B (zh) | 2014-08-06 |
CN101495513A (zh) | 2009-07-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MA29015B1 (fr) | Agents de liaison specifiques de l'angiopoietine-2 | |
NO20041907L (no) | Angiopoietin-2 spesifikke bindinsmidler | |
DE602004019159D1 (de) | Drosselklappenstutzen | |
FR2871145B1 (fr) | Distributeur d'applicateurs | |
GB0307671D0 (en) | Improvements relating to the construction of playing surfaces | |
DE60134988D1 (de) | Verknüpfbare elastomerzusammensetzung | |
FR2875398B1 (fr) | Implant articulaire d'interposition | |
MA28812B1 (fr) | Combinaisons d'epothilone | |
FR2879635B1 (fr) | Connecteur d'ossature | |
GB0510474D0 (en) | Q's vaginometer | |
DE602004017295D1 (de) | Drosselkörper | |
ZA200709553B (en) | Player's outfit | |
IL190045A0 (en) | Use of c3-c10 17 alfa-esters of 9,11-dehydrocortexolone as anti-gonadotrophic agents | |
FR2879109B1 (fr) | Composition absorbante d'humidite | |
FR2853380B1 (fr) | Articulation elastique | |
GB0403791D0 (en) | 'Kwicap' | |
FR2878004B3 (fr) | Ferrure d'angle | |
FR2852042B1 (fr) | Piece d'aretier | |
ITSV20040008A1 (it) | Dottor "g" | |
ITMN20040010A1 (it) | Portamenu' | |
ES1054827Y (es) | "purificador de gasoil" | |
FR2862726B1 (fr) | Organe de liaison | |
GB0406046D0 (en) | Affinity purification of protein | |
ITRI20050001U1 (it) | Kit dell'amatriciana | |
FR2850688B1 (fr) | Element de liaison d'entrevous |